Olga Bragina

Lovelace Respiratory Research Institute

H指数:17

被引数:1,022

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?

I期临床试验：使用GRPR-拮抗剂[⁹⁹ᵐTc]Tc-DB8进行前列腺癌SPECT成像——注射的肽质量是否会产生影响？

Pharmaceutics

IF5.5

2026-03-030

OAAI

876: DRAG-REDUCING POLYMERS STABILIZE KIDNEY AND INTESTINE MICROCIRCULATION AND OXYGENATION IN RAT SEPSIS

876: 减阻聚合物可稳定大鼠脓毒症中的肾脏和肠道微循环及氧合作用

Critical Care Medicine

IF6

2026-03-030

PRE

WALL SHEAR STRESS AS A BIOMARKER OF ARTERIAL STIFFNESS IN CEREBRAL VASOSPASM AFTER ASAH

动脉壁剪切应力作为SAH后脑血管痉挛中动脉僵硬的生物标志物

Critical Care Medicine

IF6

2026-03-010

PRE

DRAG-REDUCING POLYMERS MITIGATE MORTALITY AND ENCEPHALOPATHY IN RAT CASP SEPSIS

降阻聚合物减轻大鼠CASP脓毒症中的死亡率和脑病

Critical Care Medicine

IF6

2026-03-010

PRE

DRAG-REDUCING POLYMERS IMPROVE CEREBROVASCULAR FUNCTION IN A SWINE TBI AND HEMORRHAGIC SHOCK MODEL

减阻聚合物改善猪TBI和失血性休克模型中的脑血管功能

Critical Care Medicine

IF6

2026-03-010

PRE

LAMIFLO™ ENHANCES COLLATERAL FLOW AND REDUCES INFARCT AND BBB DAMAGE AFTER EXPERIMENTAL STROKE

LAMIFLO™ 增强侧支血流并减少实验性卒中后的梗死和BBB损伤

Critical Care Medicine

IF6

2026-03-010

PRE

Selection of the optimal chelator for labeling of DARPin Ec1 with gallium-68 for PET imaging of EpCAM expression

用于EpCAM表达PET成像的DARPin Ec1与镓-68标记的最佳螯合剂选择

EJNMMI Radiopharmacy and Chemistry

IF3.3

2025-05-300

OAAI

Ticks and Tick-Borne Pathogens in Popular Recreational Areas in Tallinn, Estonia: The Underestimated Risk of Tick-Borne Diseases

MICROORGANISMS

IF4.2

2024-09-200

OAAI

EpCAM-CD24+circulating cells associated with poor prognosis in breast cancer patients

SCIENTIFIC REPORTS

IF3.9

2024-05-284

OAAI

Affibody PET Imaging of HER2-Expressing Cancers as a Key to Guide HER2-Targeted Therapy

BIOMEDICINES

IF3.9

2024-05-148

OAAI

Evaluation of Approaches for the Assessment of HER2 Expression in Breast Cancer by Radionuclide Imaging Using the Scaffold Protein [99mTc]Tc-ADAPT6

使用支架蛋白 [99mTc]Tc-ADAPT6通过放射性核素成像评估乳腺癌中HER2表达的方法的评估

PHARMACEUTICS

IF5.5

2024-03-231

OAAI

Single cell transcriptomics of the immune cells during chemotherapy in triple-negative breast cancer patients

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

PRE

Transcriptome changes of immune cells across chemotherapy of triple-negative breast cancer

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

Sex-specific And Dose-dependent Effects Of Drag-reducing Polymers On Post-traumatic Ischemia In Rats After Traumatic Brain Injury Of Different Severity

STROKE

IF8.9

2023-02-010

PRE

Phase I clinical evaluation of 99mTc-labeled Affibody molecule for imaging HER2 expression in breast cancer

THERANOSTICS

IF13.3

2023-01-0112

OAAI

Molecular subtype conversion in CTCs as indicator of treatment adequacy associated with metastasis-free survival in breast cancer

SCIENTIFIC REPORTS

IF3.9

2022-12-055

OAAI

Phase I Clinical Trial Using [99mTc]Tc-1-thio-D-glucose for Diagnosis of Lymphoma Patients

PHARMACEUTICS

IF5.5

2022-06-152

OAAI

Experimental Therapy of HER2-Expressing Xenografts Using the Second-Generation HER2-Targeting Affibody Molecule 188Re-ZHER2:41071

PHARMACEUTICS

IF5.5

2022-05-208

OAAI

Phase I Trial of 99mTc-(HE)3-G3, a DARPin-Based Probe for Imaging of HER2 Expression in Breast Cancer

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2021-08-1239

OAAI

Phase I Study of 99mTc-ADAPT6, a Scaffold Protein-Based Probe for Visualization of HER2 Expression in Breast Cancer

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2020-08-1746

OAAI

Olga Bragina

个人简介

教育背景

工作经历

荣誉奖项

研究方向